SEC Company Response from Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196) (CANF) — Oct 4, 2017
Can-Fite BioPharma Ltd. (CANF) (CIK 0001536196)
Date: Oct. 4, 2017 · CIK: 0001536196 · Accession: 0001213900-17-010286
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220644
Referenced dates: October 2, 2017
Letter
Re: Can-Fite BioPharma Ltd.
October 4, 2017
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form F-3
File No. 333-220644
VIA EDGAR
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. (the “Company”) hereby withdraws its acceleration request letter dated October 2, 2017, which requested that the effective date of the Registration Statement on Form F-3 referenced above be accelerated so that it would have become effective at 4.00pm ET on October 4, 2017.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
Show Raw Text
CORRESP
1
filename1.htm
October 4, 2017
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Can-Fite BioPharma Ltd.
Registration Statement on Form F-3
File No. 333-220644
VIA EDGAR
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. (the “Company”)
hereby withdraws its acceleration request letter dated October 2, 2017, which requested that the effective date of the Registration
Statement on Form F-3 referenced above be accelerated so that it would have become effective at 4.00pm ET on October 4, 2017.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
By:
/s/ Pnina Fishman, Ph.D.
Name: Pnina Fishman, Ph.D.
Title: Chief Executive
Officer
cc: Gary Emmanuel (McDermott Will & Emery LLP)